Vibration Response Imaging (VRI) in Lung Transplant Recipients
NCT ID: NCT00744822
Last Updated: 2008-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2006-03-31
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Patients who meet the study inclusion and exclusion criteria will be enrolled in the study.
* The enrolled patients will be recorded with the VRI at each occurrence in which the standard procedures are performed:
* Baseline after study enrollment (VRI Recording 1 + standard evaluations).
* At each follow-up visit \[1, 3, 6 months after baseline visit\] during the 6 month follow-up period of the study (VRI Recordings + standard evaluations (if possible)).
* In the event of bronchoscopic intervention, then before the interventional procedure (VRI Recording 1 + standard evaluations) and before any recurrent interventional procedures (VRI Recordings + standard evaluations) during the course of the study (6-month follow-up period).
* 1 hour after all bronchoscopic interventional procedures.
* In the event of an unanticipated visit, then a VRI recording will be performed (VRI Recordings + standard evaluations).
* All subjects will be recorded according to a standard procedure; moreover, it is essential that for each subject repeatable recordings will be performed in the same manner (i.e. breathing manner and matrix placement). Each VRI recording session will take \~15 minutes \[the actual recording is \~2 minutes for placement and breathing/recording\].
* Standard evaluation procedures may include any of the following:
* Lung function tests (this test is required at all visits)
* Physical examination
* Bronchoscopy (e.g. transbronchial biopsy)
* CT-imaging
* Chest x-ray
* V/Q Scan (Baseline visit for single lung transplantation)
* Blood gases (this test is required at all visits)
* Blood tests
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Male or Female in the age range of 18-65 years
3. Subject is a lung transplant recipient who underwent single or double lung transplantation within the last 6 months
4. BMI \> 19
5. Height of \>1.55 meters
6. Stable clinical condition at study baseline evaluation
Exclusion Criteria
1. Intubated patients
2. Chest wall deformation
3. Spine deformation (including severe scoliosis)
4. Hirsutism
5. Potentially contagious skin lesion on the back
6. Skin lesion that would interfere with sensor placement
7. Cardiac pacemaker or implantable defibrillator
8. Patient is pregnant as confirmed with urine pregnancy test
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Deep Breeze
INDUSTRY
Hannover Medical School
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Deep Breeze Ltd.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tobias Welte, MD
Role: PRINCIPAL_INVESTIGATOR
Hannover Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hannover Medical School
Hanover, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4066
Identifier Type: -
Identifier Source: org_study_id